Analyst Coverage Initiation

Citizens Research began coverage of Tesla Inc. on 9 July 2026, assigning a Market Perform rating. Analyst Andrew Boone noted the firm’s interest stems from the potential of “physical AI,” likening the opportunity to the current acceleration of knowledge‑work AI.

Rationale and Concerns

Citizens highlighted that while Tesla possesses key assets—leading autonomy models, in‑house silicon, advanced manufacturing capabilities, state‑of‑the‑art batteries, and CEO Elon Musk’s engineering expertise—the company’s Optimus robot and Robotaxi ambitions are likely to take longer than market expectations. The firm expects Optimus to encounter a new level of production complexity, leading to delays and greater spending, positioning Tesla at the start of an Optimus investment cycle. Regarding Robotaxis, Citizens doubts the sufficiency of Tesla’s camera‑only autonomous system compared with platforms that combine LiDAR, radar, and cameras, forecasting significantly more incidents than leading AV systems, which could raise liability concerns or trigger service pauses.

Financial Forecast Adjustments

Citizens revised its revenue outlook, estimating Tesla’s 2027 revenue to be 4% below consensus estimates and its 2028 revenue to be 12% below consensus. The analysts derived these adjustments from the anticipated production challenges and higher capital outlays associated with the new product lines.

Valuation Metrics

At the close of the trading day on Wednesday, Tesla shares traded at $394.06. Using this price, Citizens calculated an implied EV/EBITDA multiple of 70.2× and an EV/Revenue multiple of 10.8× for the 2028 fiscal year. Both multiples exceed those of comparable auto and energy peers, a premium that Citizens argues is justified by Tesla’s optionality in emerging AI‑driven mobility and robotics segments.

Conclusion

Citizens’ coverage initiation underscores a cautious stance: while acknowledging Tesla’s technological strengths, the firm warns that near‑term optimism for Optimus and Robotaxi may be overstated, leading to lower revenue forecasts and a valuation premium that reflects significant execution risk.